BDBM50187859 4-(2,3-dihydro-1H-tetrazol-5-yl)-5-(3,5-dimethoxyphenylamino)isothiazol-3-ol::CHEMBL210072
SMILES: COc1cc(Nc2s[nH]c(=O)c2C2=NNNN2)cc(OC)c1
InChI Key: InChIKey=NPFCLSDFKLVLKN-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dual specificity mitogen-activated protein kinase kinase 1 (Homo sapiens (Human)) | BDBM50187859 (4-(2,3-dihydro-1H-tetrazol-5-yl)-5-(3,5-dimethoxyp...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Valeant Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Inhibition of MEK1 | Bioorg Med Chem Lett 16: 3975-80 (2006) Article DOI: 10.1016/j.bmcl.2006.05.019 BindingDB Entry DOI: 10.7270/Q2SJ1K6C | |||||||||||
More data for this Ligand-Target Pair |